MCID: ATS069
MIFTS: 25

Autosomal Dominant Optic Atrophy Plus Syndrome

Categories: Ear diseases, Eye diseases, Genetic diseases, Metabolic diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Autosomal Dominant Optic Atrophy Plus Syndrome

MalaCards integrated aliases for Autosomal Dominant Optic Atrophy Plus Syndrome:

Name: Autosomal Dominant Optic Atrophy Plus Syndrome 54 30 6
Optic Atrophy with or Without Deafness, Ophthalmoplegia, Myopathy, Ataxia, and Neuropathy 54 74
Dominant Optic Atrophy, Deafness, Ptosis, Ophthalmoplegia, Dystaxia, and Myopathy 54
Optic Atrophy-Deafness-Polyneuropathy-Myopathy Syndrome 54
Optic Atrophy - Deafness- Polyneuropathy - Myopathy 54
Dominant Optic Atrophy Plus Syndrome 54
Treft-Sanborn-Carey Syndrome 54
Treft Sanborn Carey Syndrome 74

Classifications:



Summaries for Autosomal Dominant Optic Atrophy Plus Syndrome

NIH Rare Diseases : 54 Autosomal dominant optic atrophy plus syndrome (ADOA plus) is a rare syndrome that causes vision loss, hearing loss, and symptoms affecting the muscles. The syndrome is associated with degeneration of the optic nerve (optic atrophy). The optic nerve sends signals about what the eyes are seeing to the brain. When there is optic nerve damage, it causes vision loss. Other symptoms of ADOA plus include sensorineural hearing loss and symptoms affecting the muscles such as muscle pain and weakness. ADOA plus is caused by changes (mutations) in the OPA1 gene. The syndrome is inherited in an autosomal dominant manner. A diagnosis of ADOA plus is suspected when an eye exam finds degeneration of the optic nerve (optic atrophy). The diagnosis can be confirmed with a muscle biopsy and genetic testing of the OPA1 gene. Treatment options include visual and hearing aids. Certain medications have been found to help improve vision loss in some people.

MalaCards based summary : Autosomal Dominant Optic Atrophy Plus Syndrome, also known as optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy, is related to optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy and wolfram-like syndrome, autosomal dominant, and has symptoms including ataxia and ophthalmoplegia. An important gene associated with Autosomal Dominant Optic Atrophy Plus Syndrome is OPA1 (OPA1 Mitochondrial Dynamin Like GTPase). Affiliated tissues include brain, testes and eye, and related phenotypes are sensorineural hearing impairment and optic atrophy

Related Diseases for Autosomal Dominant Optic Atrophy Plus Syndrome

Diseases in the Primary Optic Atrophy family:

Optic Atrophy 3, Autosomal Dominant Optic Atrophy 1
Optic Atrophy 6 Optic Atrophy 2
Optic Atrophy 4 Optic Atrophy 5
Optic Atrophy 9 Optic Atrophy 8
Optic Atrophy 11 Autosomal Dominant Optic Atrophy Plus Syndrome

Diseases related to Autosomal Dominant Optic Atrophy Plus Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 optic atrophy with or without deafness, ophthalmoplegia, myopathy, ataxia, and neuropathy 12.8
2 wolfram-like syndrome, autosomal dominant 11.6
3 optic atrophy 1 11.3
4 3-methylglutaconic aciduria, type iii 10.5
5 ptosis 10.5
6 myopathy 10.5
7 mitochondrial dna depletion syndrome 14 9.5 LOC102724808 OPA1

Graphical network of the top 20 diseases related to Autosomal Dominant Optic Atrophy Plus Syndrome:



Diseases related to Autosomal Dominant Optic Atrophy Plus Syndrome

Symptoms & Phenotypes for Autosomal Dominant Optic Atrophy Plus Syndrome

Human phenotypes related to Autosomal Dominant Optic Atrophy Plus Syndrome:

33 (show all 9)
# Description HPO Frequency HPO Source Accession
1 sensorineural hearing impairment 33 hallmark (90%) HP:0000407
2 optic atrophy 33 hallmark (90%) HP:0000648
3 impaired pain sensation 33 hallmark (90%) HP:0007328
4 visual impairment 33 frequent (33%) HP:0000505
5 reduced tendon reflexes 33 frequent (33%) HP:0001315
6 abnormality of color vision 33 frequent (33%) HP:0000551
7 abnormality of visual evoked potentials 33 occasional (7.5%) HP:0000649
8 strabismus 33 occasional (7.5%) HP:0000486
9 decreased nerve conduction velocity 33 occasional (7.5%) HP:0000762

UMLS symptoms related to Autosomal Dominant Optic Atrophy Plus Syndrome:


ataxia, ophthalmoplegia

Drugs & Therapeutics for Autosomal Dominant Optic Atrophy Plus Syndrome

Search Clinical Trials , NIH Clinical Center for Autosomal Dominant Optic Atrophy Plus Syndrome

Genetic Tests for Autosomal Dominant Optic Atrophy Plus Syndrome

Genetic tests related to Autosomal Dominant Optic Atrophy Plus Syndrome:

# Genetic test Affiliating Genes
1 Autosomal Dominant Optic Atrophy Plus Syndrome 30

Anatomical Context for Autosomal Dominant Optic Atrophy Plus Syndrome

MalaCards organs/tissues related to Autosomal Dominant Optic Atrophy Plus Syndrome:

42
Brain, Testes, Eye

Publications for Autosomal Dominant Optic Atrophy Plus Syndrome

Articles related to Autosomal Dominant Optic Atrophy Plus Syndrome:

# Title Authors Year
1
Dominant optic atrophy, deafness, ptosis, ophthalmoplegia, dystaxia, and myopathy. A new syndrome. ( 6493699 )
1984

Variations for Autosomal Dominant Optic Atrophy Plus Syndrome

ClinVar genetic disease variations for Autosomal Dominant Optic Atrophy Plus Syndrome:

6 (show all 24)
# Gene Variation Type Significance SNP ID Assembly Location
1 OPA1 NM_015560.2(OPA1): c.1346delC (p.Thr449Lysfs) deletion Likely pathogenic rs794729196 GRCh37 Chromosome 3, 193361797: 193361797
2 OPA1 NM_015560.2(OPA1): c.1346delC (p.Thr449Lysfs) deletion Likely pathogenic rs794729196 GRCh38 Chromosome 3, 193644008: 193644008
3 OPA1 NM_015560.2(OPA1): c.113_130del18 (p.Arg38_Ser43del) deletion Conflicting interpretations of pathogenicity rs863224140 GRCh38 Chromosome 3, 193614803: 193614820
4 OPA1 NM_015560.2(OPA1): c.113_130del18 (p.Arg38_Ser43del) deletion Conflicting interpretations of pathogenicity rs863224140 GRCh37 Chromosome 3, 193332592: 193332609
5 OPA1 NM_015560.2(OPA1): c.1745A> G (p.Tyr582Cys) single nucleotide variant Pathogenic rs121908376 GRCh37 Chromosome 3, 193365898: 193365898
6 OPA1 NM_015560.2(OPA1): c.1745A> G (p.Tyr582Cys) single nucleotide variant Pathogenic rs121908376 GRCh38 Chromosome 3, 193648109: 193648109
7 OPA1 NM_015560.2(OPA1): c.1334G> A (p.Arg445His) single nucleotide variant Pathogenic rs80356529 GRCh37 Chromosome 3, 193361785: 193361785
8 OPA1 NM_015560.2(OPA1): c.1334G> A (p.Arg445His) single nucleotide variant Pathogenic rs80356529 GRCh38 Chromosome 3, 193643996: 193643996
9 OPA1 NM_015560.2(OPA1): c.2848_2849delGA (p.Asp950Cysfs) deletion Pathogenic rs879255513 GRCh38 Chromosome 3, 193692092: 193692093
10 OPA1 NM_015560.2(OPA1): c.2848_2849delGA (p.Asp950Cysfs) deletion Pathogenic rs879255513 GRCh37 Chromosome 3, 193409881: 193409882
11 OPA1 NM_015560.2(OPA1): c.1294A> G (p.Ile432Val) single nucleotide variant Pathogenic rs387906899 GRCh37 Chromosome 3, 193361398: 193361398
12 OPA1 NM_015560.2(OPA1): c.1294A> G (p.Ile432Val) single nucleotide variant Pathogenic rs387906899 GRCh38 Chromosome 3, 193643609: 193643609
13 OPA1 NM_015560.2(OPA1): c.1635C> G (p.Ser545Arg) single nucleotide variant Pathogenic rs398124298 GRCh37 Chromosome 3, 193364899: 193364899
14 OPA1 NM_015560.2(OPA1): c.1635C> G (p.Ser545Arg) single nucleotide variant Pathogenic rs398124298 GRCh38 Chromosome 3, 193647110: 193647110
15 OPA1 NM_015560.2(OPA1): c.1316G> T (p.Gly439Val) single nucleotide variant Pathogenic rs387906900 GRCh37 Chromosome 3, 193361767: 193361767
16 OPA1 NM_015560.2(OPA1): c.1316G> T (p.Gly439Val) single nucleotide variant Pathogenic rs387906900 GRCh38 Chromosome 3, 193643978: 193643978
17 OPA1 NM_015560.2(OPA1): c.2729T> A (p.Val910Asp) single nucleotide variant Pathogenic rs387906901 GRCh37 Chromosome 3, 193384980: 193384980
18 OPA1 NM_015560.2(OPA1): c.2729T> A (p.Val910Asp) single nucleotide variant Pathogenic rs387906901 GRCh38 Chromosome 3, 193667191: 193667191
19 OPA1 NM_130837.2(OPA1): c.1817G> A (p.Cys606Tyr) single nucleotide variant Pathogenic rs879255592 GRCh37 Chromosome 3, 193364916: 193364916
20 OPA1 NM_130837.2(OPA1): c.1817G> A (p.Cys606Tyr) single nucleotide variant Pathogenic rs879255592 GRCh38 Chromosome 3, 193647127: 193647127
21 OPA1 NM_015560.2(OPA1): c.985-2A> G single nucleotide variant Pathogenic rs886041317 GRCh37 Chromosome 3, 193360552: 193360552
22 OPA1 NM_015560.2(OPA1): c.985-2A> G single nucleotide variant Pathogenic rs886041317 GRCh38 Chromosome 3, 193642763: 193642763
23 OPA1 NM_015560.2(OPA1): c.344C> T (p.Ala115Val) single nucleotide variant Uncertain significance rs200983556 GRCh37 Chromosome 3, 193332823: 193332823
24 OPA1 NM_015560.2(OPA1): c.344C> T (p.Ala115Val) single nucleotide variant Uncertain significance rs200983556 GRCh38 Chromosome 3, 193615034: 193615034

Expression for Autosomal Dominant Optic Atrophy Plus Syndrome

Search GEO for disease gene expression data for Autosomal Dominant Optic Atrophy Plus Syndrome.

Pathways for Autosomal Dominant Optic Atrophy Plus Syndrome

GO Terms for Autosomal Dominant Optic Atrophy Plus Syndrome

Sources for Autosomal Dominant Optic Atrophy Plus Syndrome

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....